New cancer therapies in 2022 achieving unprecedented remissions - reviewing a year of hope
Including gene editing, immunotherapy, modified viruses, vaccines, personalised medicine, and nanotechnology
Join the club for FREE to access the whole archive and other member benefits.
BBC - 25-Apr-2024
Trial shows promising results for a potential cure, targeting individual cancer cells
Read more...Independent - 08-Apr-2024
Test offers minimal benefit but risks overtreating slow-growing cancers
Read more...BBC - 21-Mar-2024
In an NHS trial, the system successfully identified cancers missed by human doctors
Read more...Independent - 18-Mar-2024
It may improvepatient outcomes and advance personalised cancer treatment
Read more...Johns Hopkins University (JHU) - 27-Feb-2024
ASTR to revolutionize cancer treatment with unmatched precision & minimal tissue loss
Read more...Click on resource name for more details.
Company that develops novel targeted medicines with companion biomarkers for cancer patients
Including gene editing, immunotherapy, modified viruses, vaccines, personalised medicine, and nanotechnology
Provides an early warning or peace of mind – good value for money either way